According to the government body, the topics to be discussed at the Hilton Washington DC/Rockville Hotel & Executive Meeting Center on May 15 are those also up for discussion at its forthcoming ICCR Steering Committee meeting.
Opportunity to have a say…
“The purpose of the meeting is to solicit public input prior to the next steering committee and expert working group meetings on July 10 to 13,” says a FDA spokesperson.
Furthermore, the FDA says the public will have the opportunity to present data, information or views orally or in writing, on issues pending providing “those desiring to make oral presentations should notify us by May 9, and submit a brief statement of the general nature of the evidence or arguments they wish to present with an estimated time and company information.”
Rules and regulation
CFSAN's Office of Cosmetic and Colors is responsible for the federal regulation of cosmetic products in the US and regulates cosmetics under the Federal Food, Drug, and Cosmetic Act (the FD Act) (21 U.S.C. 301 et seq.) and, for products marketed on a retail basis to consumers, under the Fair Packaging and Labeling Act (FPLA) (15 U.S.C. 1451 et seq.).
The law requires that cosmetics must be safe for consumers under labeled or customary conditions of use and they must be properly labeled.
A transcript of the meeting will be available in either hardcopy or on CD-ROM, after submission of a Freedom of Information request, accessible at http://www.regulations.gov.
For more information on how to register etc. please click here.